Nocturne Company
%20.jpg)
Nocturne diagnoses neurological disorders with retinal image analysis. Nocturne’s proprietary technology (patent pending) analyses 3D images of the retina, which are obtained by optical coherence tomography (OCT). OCT is a noninvasive imaging technology routinely used in ophthalmology. Standard OCT devices are affordable but are by themselves of only limited value for neurologic applications. Nocturne was founded in Berlin, Germany, in February 2018. The founding team comprises one medical image analysis expert, one mathematical modelling expert, one clinical neuroscientist and neurodiagnostics expert and one leading neurologist as scientific advisor.
Total Funding:
€71.4K
Headquarters:
Berlin, Berlin, Germany
Funding Status:
Seed
Employee Number:
1-10
Last Funding Type:
Grant
Technology:
P4 Medicine
Investor Type:
For Profit
Investors Number:
3
Founded Date:
2018-01-01
Industry:
Biotechnology, Health Care, Science and Engineering, Software